Company profile
Home | GSK
At GSK, we unite science, technology and talent to get ahead of disease together
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQ0MjM4NjU3OWFkaXF6a2N4
Published 07 Nov 2024 02:49
CH03 | Transaction MzQzNjY4MTAyNGFkaXF6a2N4
Published 23 Sep 2024 06:02
AA | Transaction MzQzNjQ5OTE5OGFkaXF6a2N4 | Paper/PDF filed
Published 23 Sep 2024 05:37
CH01 | Transaction MzQzNjAzMjEwMGFkaXF6a2N4
Published 17 Sep 2024 06:54
PSC05 | Transaction MzQzNTI0NDMxNWFkaXF6a2N4
Published 02 Oct 2024 01:55
AD01 | Transaction MzQzNTIyMjQwNWFkaXF6a2N4
Published 11 Sep 2024 02:01
Company registered at Companies House
1 Aug 2016 to 31 Jul 2019
Clavulanic acid (CA) is a beta-lactamase inhibitor able to potentiate the antibacterial activity of penicillins against otherwise resistant bacteria. It is the product of complex biological factories found naturally in Streptomyces clavuligerus, and is currently made industrially via fermentation using a strain that has been through successive rounds of n...
1 Jul 2015 to 30 Jun 2018
Natural or engineered biosynthesis can replace chemical synthesis with more environmentally friendly, sustainable bio-manufacturing processes to generate small molecule products such as pharmaceuticals. Although expression systems for recombinant proteins have been developed for laboratory scale and for commercial expression of very high value products su...
